NCT03958383 2025-04-18IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for MelanomaUniversity of Wisconsin, MadisonPhase 1/2 Active not recruiting8 enrolled
NCT05662397 2025-02-04A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 AntibodyHotSpot Therapeutics, IncPhase 1/2 Active not recruiting77 enrolled